Last A$0.02 AUD
Change Today 0.00 / 0.00%
Volume 2.2M
GTG On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
Frankfurt
As of 6:13 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ivan Jasenko BAppSc (Hons)

Former Operations Director, Genetic Technologies Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48A$23,101
As of Fiscal Year 2014

Background*

Mr. Ivan Jasenko, BAppSc (Hons) serves as Operations Director of Genetic Technologies Limited from December 10, 2012 to August 16, 2013. Mr. Jasenko served as the Quality and Regulatory Manager at Genetic Technologies Limited since August 16, 2010. Mr. Jasenko has over ten years local and international Biopharmaceutical experience in both human and animal health in Quality and Regulatory roles, particularly with FDA and TGA compliance ranging from the manufacture of ...

Read Full Background

Corporate Headquarters*

60-66 Hanover Street
Fitzroy, Victoria 3065

Australia

Phone: 61 3 8412 7000
Fax: 61 3 8412 7040

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

SalaryA$20,470
Total Annual CompensationA$20,470

Stock Options*

All Other CompensationA$14,787

Total Compensation*

Total Annual Cash CompensationA$35,257
Total Short Term CompensationA$20,470
Other Long Term CompensationA$14,787
Total Calculated CompensationA$23,101
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTG:AU A$0.02 AUD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William P. Sullivan Chief Executive Officer, Executive Director and Member of Executive Committee
Agilent Technologies Inc.
$1.0M
Colin Stephen Goldschmidt M.B., B.Ch., F.R.C.P.A., F.A.I.C.D.Chief Executive Officer, Managing Director, Executive Director, Member of Risk Management Committee and Chief Executive Officer of Douglass Hanly Moir Pathology
Sonic Healthcare Limited
A$3.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETIC TECHNOLOGIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.